Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Clinical trial NCT05879484 · WITHDRAWN

Trial details

NCT number: NCT05879484
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sinonasal Cancer Squamous Non-small Cell Lung Cancer Lung Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Carcnimona Head and Neck Cancer

Start date: 2025-07-09
Primary completion: 2025-07-09
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.